(Reuters) – GlaxoSmithKline PLC said on Thursday it has signed agreements with the Canadian government to supply 20,000 doses of the COVID-19 drug Sotrovimab.
The new purchase agreement follows October’s initial purchase agreement with Canada to supply 10,000 doses of Sotrovimab.
(Reporting by Leroy Leo; Editing by Devika Syamnath)
